<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang JX</submitter><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>1489-98</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3423786</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(7)</volume><pubmed_abstract>Ly6G is a glycosylphosphatidylinositol (GPI)-anchored protein of unknown function that is commonly targeted to induce experimental neutrophil depletion in mice. In the present study, we found that doses of anti-Ly6G Abs too low to produce sustained neutropenia remained capable of inhibiting experimental arthritis, leaving joint tissues free of infiltrating neutrophils. Thioglycollate-stimulated peritonitis was also attenuated. No alteration in neutrophil apoptosis was observed, implicating impaired recruitment. Indeed, Ly6G ligation abrogated neutrophil migration toward LTB(4) and other chemoattractants in a transwell system. Exploring the basis for this blockade, we identified colocalization of Ly6G and β2-integrins by confocal microscopy and confirmed close association by both coimmunoprecipitation and fluorescence lifetime imaging microscopy. Anti-Ly6G Ab impaired surface expression of β2-integrins in LTB(4)-stimulated neutrophils and mimicked CD11a blockade in inhibiting both ICAM-1 binding and firm adhesion to activated endothelium under flow conditions. Correspondingly, migration of β2-integrin-deficient neutrophils was no longer inhibited by anti-Ly6G. These results demonstrate that experimental targeting of Ly6G has functional effects on the neutrophil population and identify a previously unappreciated role for Ly6G as a modulator of neutrophil migration to sites of inflammation via a β2-integrin-dependent mechanism.</pubmed_abstract><journal>Blood</journal><pubmed_title>Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism.</pubmed_title><pmcid>PMC3423786</pmcid><funding_grant_id>R01 AI068871</funding_grant_id><funding_grant_id>3R01AI068871-04S</funding_grant_id><funding_grant_id>P30 AR042689</funding_grant_id><funding_grant_id>S10 RR027931</funding_grant_id><funding_grant_id>1R01HL097796</funding_grant_id><funding_grant_id>K01 DK089145</funding_grant_id><funding_grant_id>5R01-AI068871</funding_grant_id><funding_grant_id>P30 DK043351</funding_grant_id><funding_grant_id>R01 HL097796</funding_grant_id><funding_grant_id>1S10RR027931</funding_grant_id><funding_grant_id>P30 AR42689</funding_grant_id><pubmed_authors>Huang YF</pubmed_authors><pubmed_authors>Soberman RJ</pubmed_authors><pubmed_authors>Shnayder R</pubmed_authors><pubmed_authors>Bair AM</pubmed_authors><pubmed_authors>Wang JX</pubmed_authors><pubmed_authors>Nigrovic PA</pubmed_authors><pubmed_authors>Shieh CC</pubmed_authors><pubmed_authors>Fuhlbrigge RC</pubmed_authors><pubmed_authors>King SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism.</name><description>Ly6G is a glycosylphosphatidylinositol (GPI)-anchored protein of unknown function that is commonly targeted to induce experimental neutrophil depletion in mice. In the present study, we found that doses of anti-Ly6G Abs too low to produce sustained neutropenia remained capable of inhibiting experimental arthritis, leaving joint tissues free of infiltrating neutrophils. Thioglycollate-stimulated peritonitis was also attenuated. No alteration in neutrophil apoptosis was observed, implicating impaired recruitment. Indeed, Ly6G ligation abrogated neutrophil migration toward LTB(4) and other chemoattractants in a transwell system. Exploring the basis for this blockade, we identified colocalization of Ly6G and β2-integrins by confocal microscopy and confirmed close association by both coimmunoprecipitation and fluorescence lifetime imaging microscopy. Anti-Ly6G Ab impaired surface expression of β2-integrins in LTB(4)-stimulated neutrophils and mimicked CD11a blockade in inhibiting both ICAM-1 binding and firm adhesion to activated endothelium under flow conditions. Correspondingly, migration of β2-integrin-deficient neutrophils was no longer inhibited by anti-Ly6G. These results demonstrate that experimental targeting of Ly6G has functional effects on the neutrophil population and identify a previously unappreciated role for Ly6G as a modulator of neutrophil migration to sites of inflammation via a β2-integrin-dependent mechanism.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Aug</publication><modification>2026-06-04T08:17:40.057Z</modification><creation>2026-05-07T03:13:06.042Z</creation></dates><accession>S-EPMC3423786</accession><cross_references><pubmed>22661700</pubmed><doi>10.1182/blood-2012-01-404046</doi></cross_references></HashMap>